Press release

RAPID Now Available for Use in Mexico

Sponsored by Businesswire

iSchemaView, the worldwide leader in advanced imaging for stroke, has
expanded its reach across North and Latin America, as the RAPID imaging
platform is now available for use in Mexico. RAPID is designed to
provide physicians with fully automated and easy-to-interpret imaging
that facilitates timely clinical decision-making around stroke.

“Strokes are a medical emergency, and urgent treatment is essential. The
sooner a person receives treatment for a stroke, the less damage is
likely to happen. That’s why Punta Mita Hospital has acquired the most
advanced cerebrovascular imaging platform available, RAPID,” offered Dr.
Luis Alberto López Avelar, Medical Director Punta Mita Hospital. “We are
committed to offering the best quality in medical care, which is why now
with RAPID Punta Mita Hospital provides state-of-the-art technology for
the timely and accurate diagnosis of a cerebrovascular event.”

Developed by leading stroke experts, RAPID technology has been selected
for use in several ground-breaking trials that have changed treatment
guidelines issued by both the American Heart Association and American
Stroke Association. The RAPID Artificial Intelligence framework combines
deep learning, machine learning and expert feature extraction. Together
these provide unparalleled sensitivity and specificity across stroke
modules (CT perfusion, MR diffusion and perfusion, CTA and CT ASPECT
scoring). Results are then delivered by the RAPID Intelligence Services
Platform via PACS, email, text, the RAPID app or corporate partner
workflow systems.

The Complete RAPID Platform includes:

  • RAPID CTP: fully-automated perfusion maps; accurately
    quantifies reduced cerebral blood flow, cerebral blood volume and
    transit time
  • RAPID MRI: fully-automated diffusion and perfusion maps
    that quantify brain areas with low ADC values, as well as delayed
    contrast arrival
  • RAPID CTA: automatically delivers CT angiography maps and
    identifies brain regions with reduced blood vessel density in 2D and
    3D outputs
  • RAPID ASPECTS: automatically identifies areas of early
    ischemic change on non-contrast CT scans, which predicts irreversible

“Each day we work to transform stroke care, furthering our mission to
provide healthcare professionals around the globe with the most
comprehensive and intuitive suite of brain imaging solutions possible.”
said Anil Singhal, MD, SVP, Worldwide Operations at iSchemaView. “Based
on just the first quarter of this year, RAPID is already on pace to
image over 132,500 patients in 2019, process over 250,000 scans and
identify over 40,000 potential patients for thrombectomies. We will
continue to expand, across Mexico and the globe, to provide as many
hospitals as possible the tools they need to best help their patients
and improve outcomes.”

For more information about working with RAPID in Mexico, contact

About iSchemaView

iSchemaView is the worldwide leader in advanced imaging for stroke.
Installed in over 1,200 hospitals, iSchemaView’s RAPID (automated CTP,
MR, CTA and ASPECTS), with enhanced AI framework, is the most advanced
stroke imaging platform. In clinical trials, RAPID has been shown to aid
in the selection of patients in early and late-window stroke trials,
including SWIFT PRIME, EXTEND IA, DAWN, DEFUSE 3 and EXTEND. In addition
to achieving the best clinical outcomes and largest treatment effects
ever obtained, these landmark studies led to new American Heart
Association and American Stroke Association guidelines and have
dramatically altered the management of acute stroke around the
world. For more information, visit